These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31012983)

  • 1. Altered Glycemic Control Associated With Polymorphisms in the SLC22A1 (OCT1) Gene in a Mexican Population With Type 2 Diabetes Mellitus Treated With Metformin: A Cohort Study.
    Reséndiz-Abarca CA; Flores-Alfaro E; Suárez-Sánchez F; Cruz M; Valladares-Salgado A; Del Carmen Alarcón-Romero L; Vázquez-Moreno MA; Wacher-Rodarte NA; Gómez-Zamudio JH
    J Clin Pharmacol; 2019 Oct; 59(10):1384-1390. PubMed ID: 31012983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response.
    Becker ML; Visser LE; van Schaik RH; Hofman A; Uitterlinden AG; Stricker BH
    Pharmacogenet Genomics; 2010 Jan; 20(1):38-44. PubMed ID: 19898263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis.
    Peng A; Gong C; Xu Y; Liang X; Chen X; Hong W; Yan J
    Front Public Health; 2023; 11():1183879. PubMed ID: 37546319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients.
    Tarasova L; Kalnina I; Geldnere K; Bumbure A; Ritenberga R; Nikitina-Zake L; Fridmanis D; Vaivade I; Pirags V; Klovins J
    Pharmacogenet Genomics; 2012 Sep; 22(9):659-66. PubMed ID: 22735389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of
    Chen P; Cao Y; Chen S; Liu Z; Chen S; Guo Y
    Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of the SLC47A1 and SLC47A2 gene polymorphisms on the glycemic response to metformin in type 2 diabetes mellitus patients.
    Raj GM; Mathaiyan J; Wyawahare M; Priyadarshini R
    Drug Metab Pers Ther; 2018 Dec; 33(4):175-185. PubMed ID: 30433870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study.
    Zhou K; Donnelly LA; Kimber CH; Donnan PT; Doney AS; Leese G; Hattersley AT; McCarthy MI; Morris AD; Palmer CN; Pearson ER
    Diabetes; 2009 Jun; 58(6):1434-9. PubMed ID: 19336679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes: A systematic review.
    Mofo Mato EP; Guewo-Fokeng M; Essop MF; Owira PMO
    Medicine (Baltimore); 2018 Jul; 97(27):e11349. PubMed ID: 29979413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Solute Carrier Family 22 Member 1 (
    Pradana AD; Kristin E; Nugrahaningsih DAA; Nugroho AK; Pinzon RT
    Curr Diabetes Rev; 2024; 20(4):e070823219470. PubMed ID: 37550919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patients.
    Umamaheswaran G; Praveen RG; Damodaran SE; Das AK; Adithan C
    Clin Exp Med; 2015 Nov; 15(4):511-7. PubMed ID: 25492374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal assessment of SNPs rs72552763 and rs622342 in
    Ortega-Ayala A; De Andrés F; Llerena A; Bartolo-Montiel CM; Acosta-Altamirano G; Molina-Guarneros JA
    Front Pharmacol; 2024; 15():1433519. PubMed ID: 39403148
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes.
    Tkáč I; Klimčáková L; Javorský M; Fabianová M; Schroner Z; Hermanová H; Babjaková E; Tkáčová R
    Diabetes Obes Metab; 2013 Feb; 15(2):189-91. PubMed ID: 22882994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response.
    Ningrum VDA; Sadewa AH; Ikawati Z; Yuliwulandari R; Ikhsan MR; Fajriyah R
    PLoS One; 2022; 17(7):e0271410. PubMed ID: 35905099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of SLC22A1, SLC47A1, and KCNJ11 polymorphisms with efficacy and safety of metformin and sulfonylurea combination therapy in Egyptian patients with type 2 diabetes.
    Ahmed A; Elsadek HM; Shalaby SM; Elnahas HM
    Res Pharm Sci; 2023 Dec; 18(6):614-625. PubMed ID: 39005567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients.
    Xiao D; Guo Y; Li X; Yin JY; Zheng W; Qiu XW; Xiao L; Liu RR; Wang SY; Gong WJ; Zhou HH; Liu ZQ
    Int J Endocrinol; 2016; 2016():4350712. PubMed ID: 26977146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Protocol for the Study of Polymorphisms and Response to Metformin in Patients with Type 2 Diabetes in Trinidad.
    Clement Y; Singh S; Motilal S; Maharaj R; Nunez-Smith M
    Ethn Dis; 2020; 30(Suppl 1):211-216. PubMed ID: 32269463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus.
    Becker ML; Visser LE; van Schaik RH; Hofman A; Uitterlinden AG; Stricker BH
    Pharmacogenomics J; 2009 Aug; 9(4):242-7. PubMed ID: 19381165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of critical pharmacokinetic gene variants on therapeutic response to metformin in Type 2 diabetes.
    Phani NM; Vohra M; Kakar A; Adhikari P; Nagri SK; D'Souza SC; Umakanth S; Satyamoorthy K; Rai PS
    Pharmacogenomics; 2018 Jul; 19(11):905-911. PubMed ID: 29914345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of
    Ortega-Ayala A; De Andrés F; Llerena A; Bartolo-Montiel CM; Molina-Guarneros JA
    Biomed Rep; 2024 Aug; 21(2):117. PubMed ID: 38938740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of genetic factors and kidney and liver function in glycemic control in type 2 diabetes patients on long-term metformin and sulphonylurea cotreatment.
    Klen J; Goričar K; Janež A; Dolžan V
    Biomed Res Int; 2014; 2014():934729. PubMed ID: 25025077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.